KalVista Pharmaceuticals Inc (KALV)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

55 CAMBRIDGE PARKWAY CAMBRIDGE, MA 02142

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME). KalVista is developing KVD900 as an oral on-demand therapy for acute HAE attacks, which completed a Phase 2 efficacy trial in February 2021, demonstrating statistical and clinical significance across all endpoints. KVD824 is in development for prophylactic treatment of HAE with a Phase 2 clinical trial expected to initiate in the second quarter of 2021. In addition, KalVista's oral Factor XIIa inhibitor program represents a new generation of therapies that may further improve the treatment of HAE for patients. In DME, an intravitreally administered plasma kallikrein inhibitor, called KVD001, has completed a Phase 2 clinical trial.

Data as of 2021-08-02 08:43:54 -0400
Market Cap492.151 Million Shares Outstanding24.436 Million Avg 30-day Volume201.667 Thousand
P/E Ratio-12.99511 Dividend Yield EPS-2.12
Price/Sales128.7 Debt to Equity1.13 EBITDA-48.728 Million
Price to Book Value8.4 Forward PE-0.26 Enterprise Value441.84 Million
Total Cash50.311 Million Current Debt6.518 Million Gross Profit3.824 Million
BETA0.66061 52-week High/Low45.0 / 9.69 Next Earnings Date2021-09-14 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from KALV instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 117 84 39.29% 43 (2.52%) 34 (1.97%) 26.47%
13F shares: 23.582 Million 16.385 Million 43.92% 10.78 Million 8.165 Million 32.02%
% Ownership 97.0132 91.3234 6.23% 44.3455 45.5082 -2.55%
New Positions: 52 23 126.09% 23 8 187.5%
Increased Positions 43 22 95.45% 11 7 57.14%
Closed Positions 18 3 500.0% 13 1 1200.0%
Reduced Positions 17 24 -29.17% 5 12 -58.33%
Total Calls 138.724 Thousand 277.583 Thousand -50.02% 42.2 Thousand 212.548 Thousand -80.15%
Total Puts 318.546 Thousand 350.318 Thousand -9.07% 145.6 Thousand 181.4 Thousand -19.74%
PUT/CALL Ratio 2.3 1.26 82.54% 3.45 0.85 305.88%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KALV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KALV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

31 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

YEA CHRISTOPHER CHIEF DEVELOPMENT OFFICER

  • Officer
37,969 2021-08-02 9

FEENER EDWARD P. CHIEF SCIENTIFIC OFFICER

  • Officer
8,234 2021-08-02 11

CROCKETT THOMAS ANDREW CEO

  • Officer
  • Director
134,670 2021-07-01 10

SMITH MICHAEL DAVID SENIOR VP, DEVELOPMENT

  • Officer
22,596 2021-06-01 5

PALLEIKO BENJAMIN L CFO, CBO & SECRETARY

  • Officer
75,000 2021-05-26 5

MAETZEL ANDREAS SENIOR VICE PRESIDENT, MEDICAL

  • Officer
25,000 2021-05-26 4

AUDHYA PAUL K. CHIEF MEDICAL OFFICER

  • Officer
0 2021-05-01 2

STUART NANCY

  • Director
0 2021-03-18 2

CHA ALBERT

  • Director
1,138,179 2020-10-30 2

UNKART EDWARD W

  • Director
0 2020-10-01 1

ORONSKY ARNOLD L

  • Director
0 2020-10-01 1

PEREIRA BRIAN JG

  • Director
0 2020-10-01 1

SOLAND DANIEL B

  • Director
0 2020-10-01 2

EDWARDS MARTIN

  • Director
0 2020-10-01 1

SVLSF IV, LLC

SV LIFE SCIENCES FUND IV (GP), L.P.

SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.

SV LIFE SCIENCES FUND IV, L.P.

  • 10% Owner
No longer subject to file 2019-04-08 0

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VHCP CO-INVESTMENT HOLDINGS III, LLC

VHCP MANAGEMENT III, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
No longer subject to file 2019-03-18 0

ALDRICH RICHARD

  • Director
0 2018-10-03 0

SHAH RAJEEV M.

  • Director
  • 10% Owner
1,441,070 2017-10-12 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • Director
  • 10% Owner
1,441,070 2017-10-12 0

NOVO HOLDINGS A/S

  • 10% Owner
No longer subject to file 2017-10-10 0

RESNICK JOSHUA

  • Director
0 2017-09-27 0

MARONEY MARCEE VP, CLINICAL AFFAIRS

  • Officer
No longer subject to file 2016-11-21 0

RENZI DAVID PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2016-11-21 0

BASTA STEVEN L

  • Director
No longer subject to file 2016-11-21 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2016-11-21 0

SAUL DAVID JOSEPH

  • Director
0 2016-02-01 0

GRAVETT DAVID M. VP, RESEARCH & DEVELOPMENT

  • Officer
0 2016-01-04 0

RAMIYA PREMCHANDRAN VICE PRESIDENT OF SUPPLY CHAIN

  • Officer
0 2016-01-04 0

MCKUNE JOHN SEE REMARKS

  • Officer
0 2016-01-04 0

LEWIS HAYLEY SEE REMARKS

  • Officer
0 2015-08-03 0

KATKIN KEITH

  • Director
0 2015-08-03 0

ZADNO REZA

  • Director
0 2015-08-03 0

CLAPPER DAVID M

  • Director
0 2015-08-03 0

NOHRA GUY P

  • Director
4,343,550 2015-04-14 0

ACMP IV LLC

ACP IV, L.P.

JANNEY DANIEL

  • 10% Owner
4,343,550 2015-04-14 0

VIVO VENTURES VI, LLC

VIVO VENTURES FUND VI, L.P.

VIVO VENTURES VI AFFIILATES FUND, L.P.

  • 10% Owner
4,204,564 2015-04-14 0

INTERWEST MANAGEMENT PARTNERS IX, LLC

INTERWEST PARTNERS IX, LP

GIANOS PHILIP T

ORONSKY ARNOLD L

KLIMAN GILBERT H

HOLMES W STEPHEN

KJELLSON NINA S

PEPPER DOUGLAS A

CLEVELAND BRUCE A

NASR KHALED

  • 10% Owner
4,619,196 2015-04-14 0

WHITE THOMAS MICHAEL SEE REMARKS

  • Officer
0 2015-04-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FEENER EDWARD P. - Officer CHIEF SCIENTIFIC OFFICER

2021-08-04 19:55:17 -0400 2021-08-02 S 6,000 $20.52 d 8,234 direct yes

YEA CHRISTOPHER - Officer CHIEF DEVELOPMENT OFFICER

2021-08-04 19:55:58 -0400 2021-08-02 S 5,000 $20.52 d 37,969 direct yes

CROCKETT THOMAS ANDREW - Director - Officer CEO

2021-07-02 17:35:07 -0400 2021-07-01 S 4,350 $23.88 d 140,320 direct yes -0.9138 -5.0914 0.087 3 -5.0914 6

CROCKETT THOMAS ANDREW - Director - Officer CEO

2021-07-02 17:35:07 -0400 2021-07-01 S 5,650 $24.35 d 134,670 direct yes -0.9138 -5.0914 0.087 3 -5.0914 6

CROCKETT THOMAS ANDREW - Director - Officer CEO

2021-06-22 17:15:58 -0400 2021-06-17 S 1,067 $30.04 d 144,670 direct yes 4.5166 -10.5636 4.5166 2 -10.5636 6

CROCKETT THOMAS ANDREW - Director - Officer CEO

2021-06-11 19:29:12 -0400 2021-06-09 S 8,933 $30.05 d 145,737 direct yes 0.6351 -8.2216 -27.6641 5.5399 4 -27.6641 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 22:15:04 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 21:45:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 21:15:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 20:45:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 20:15:04 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 19:45:04 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 19:15:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 18:45:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 18:15:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 17:45:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 17:15:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 16:45:02 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 16:15:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 15:45:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 15:15:02 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 14:45:02 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 14:15:04 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 13:45:04 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 13:15:03 UTC -0.3065 0.3865 100000
KALVISTA PHARMACEUTICALS INC KALV 2021-08-05 12:45:03 UTC -0.3065 0.3865 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments